Wayangankar Siddharth A, Bangalore Sripal, McCoy Lisa A, Jneid Hani, Latif Faisal, Karrowni Wassef, Charitakis Konstantinos, Feldman Dmitriy N, Dakik Habib A, Mauri Laura, Peterson Eric D, Messenger John, Roe Mathew, Mukherjee Debabrata, Klein Andrew
Cleveland Clinic, Cleveland, Ohio.
New York University School of Medicine, New York, New York.
JACC Cardiovasc Interv. 2016 Feb 22;9(4):341-351. doi: 10.1016/j.jcin.2015.10.039. Epub 2016 Jan 20.
The purpose of this study was to examine the temporal trends in demographics, clinical characteristics, management strategies, and in-hospital outcomes in patients with acute myocardial infarction complicated by cardiogenic shock (CS-AMI) who underwent percutaneous coronary intervention (PCI) from the Cath-PCI Registry (2005 to 2013).
The authors examined contemporary use and outcomes of PCI in patients with CS-AMI.
The authors used the Cath-PCI Registry to evaluate 56,497 patients (January 2005 to December 2013) undergoing PCI for CS-AMI. Temporal trends in clinical variables and outcomes were assessed.
Compared with cases performed from 2005 to 2006, CS-AMI patients receiving PCI from 2011 to 2013 were more likely to have diabetes, hypertension, dyslipidemia, previous PCI, dialysis, but less likely to have chronic lung disease, peripheral vascular disease, or heart failure within 2 weeks (p < 0.01). Between 2005 and 2006 to 2011 and 2013, intra-aortic balloon pump use decreased (49.5% to 44.9%; p < 0.01), drug-eluting stent use declined (65% to 46%; p < 0.01), and the use of bivalirudin increased (12.6% to 45.6%). Adjusted in-hospital mortality; increased (27.6% in 2005 to 2006 vs. 30.6% in 2011 to 2013, adjusted odds ratio: 1.09, 95% confidence interval: 1.005 to .173; p = 0.04) for patients who were managed with an early invasive strategy (<24 h from symptoms).
Our study shows that despite the evolution of medical technology and use of contemporary therapeutic measures, in-hospital mortality in CS-AMI patients who are managed invasively continues to rise. Additional research and targeted efforts are indicated to improve outcomes in this high-risk cohort.
本研究旨在探讨2005年至2013年期间,接受经皮冠状动脉介入治疗(PCI)的急性心肌梗死合并心源性休克(CS-AMI)患者在人口统计学、临床特征、管理策略及住院结局方面的时间趋势。
作者研究了当代CS-AMI患者PCI的使用情况及结局。
作者利用Cath-PCI注册研究评估了56497例2005年1月至2013年12月期间接受PCI治疗的CS-AMI患者。评估临床变量及结局的时间趋势。
与2005年至2006年进行的病例相比,2011年至2013年接受PCI的CS-AMI患者更易患糖尿病、高血压、血脂异常、既往接受过PCI、透析,但在2周内患慢性肺病、外周血管疾病或心力衰竭的可能性较小(p<0.01)。在2005年至2006年至2011年至2013年期间,主动脉内球囊泵的使用减少(49.5%至44.9%;p<0.01),药物洗脱支架的使用下降(65%至46%;p<0.01),比伐卢定的使用增加(12.6%至45.6%)。对于采用早期侵入性策略(症状出现后<24小时)治疗的患者,调整后的住院死亡率有所增加(2005年至2006年为27.6%,2011年至2013年为30.6%,调整后的优势比:1.09,95%置信区间:1.005至1.173;p=0.04)。
我们的研究表明,尽管医疗技术有所发展且采用了当代治疗措施,但侵入性治疗的CS-AMI患者的住院死亡率仍在上升。需要进一步的研究和针对性努力以改善这一高危人群的结局。